About Delphilin
Delphilin (GRID2IP) is a protein
from Homo sapiens identified by UniProt accession
A4D2P6, 1211 residues long.
MolForge cross-references it against 0 known binders and
42 disease associations.
Target properties
| Protein name | Delphilin |
|---|
| UniProt accession | A4D2P6 |
|---|
| Gene | GRID2IP |
|---|
| Organism | Homo sapiens |
|---|
| Length | 1211 residues |
|---|
| Molecular weight | — |
|---|
| EC numbers | — |
|---|
| Target class | UNCLASSIFIED |
|---|
| Subcellular location | — |
|---|
| Keywords | — |
|---|
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
|---|
| Druggability score | — |
|---|
| Pocket score | — |
|---|
| Max clinical phase | — |
|---|
Disease associations (42)
Diseases linked to this target (Open Targets).
- self reported educational attainment · score 0.37
- neurodegenerative disease · score 0.21
- inflammatory bowel disease · score 0.20
- blood protein measurement · score 0.12
- Alzheimer disease · score 0.12
- body fat percentage · score 0.12
- neutrophil count · score 0.11
- lymphocyte count · score 0.11
- Red cell distribution width · score 0.09
- leukocyte count · score 0.09
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
|---|
| AF-A4D2P6-F1 | alphafold | PREDICTED | 66.35 | — |
Amino-acid sequence (1211 residues)
MATTATPATN QGWPEDFGFR LGGSGPCFVL EVAKGSSAHA GGLRPGDQIL EVEGLAVGGL SRERLVRLAR RCPRVPPSLG VLPAPDGGPG PGSGPAAPTT VLRAPRCGRG LALGRELLRL AGRKRPDAVH RERRRKAQEF SRKVDEILGD QPTAKEQVFA ALKQFAAEQR VDDLVWTLTL ALPREACGPL LDNLRIFIPK KHRARFDEVV SQGLLGKLCR ARRAQGAQRL RRSRSEERPE RLLVSTRASA PPRRPDEPPP RRASLLVGGL AGPGGARRTV RVYKGNKSFG FTLRGHGPVW IESVLPGSPA DNAALKSGDR ILFLNGLDMR NCSHDKVVSM LQGSGAMPTL VVEEGLVPFA SDSDSLDSPN PSSALTSLQW VAEILPSSIR VQGRTFSQQL EHLLTPPERY GVCRALESFF QHRNIDTLIV DVYPVLDTPA KQVLWQFIYQ LLTYEEQELC QEKIACFLGY TAMTAEPEPE LDLESEPTPE PQPRSSLRAS SMCRRSLRSQ GLEAGLSCGP SECPEMPLPL IPGERQAGDG TSLPETPNPK MMSAVYAELE SRLNSSFKGK MGTVSKSRAS PPGPSPAVTT GPRTLSGVSW PSERLLPSPC YHPLCSGGLA SPSSSESHPY ASLDSSRAPS PQPGPGPICP DSPPSPDPTR PPSRRKLFTF SHPVRSRDTD RFLDVLSEQL GPRVTIVDDF LTPENDYEEM SFHDDQGSFV TNERSSASDC ISSSEEGSSL TYSSISDHIP PPPLSPPPPP PLPFHDAKPS SRSSDGSRGP AQALAKPLTQ LSHPVPPPPP PPLPPPVPCA PPMLSRGLGH RRSETSHMSV KRLRWEQVEN SEGTIWGQLG EDSDYDKLSD MVKYLDLELH FGTQKPAKPV PGPEPFRKKE VVEILSHKKA YNTSILLAHL KLSPAELRQV LMSMEPRRLE PAHLAQLLLF APDADEEQRY QAFREAPGRL SEPDQFVLQM LSVPEYKTRL RSLHFQATLQ EKTEEIRGSL ECLRQASLEL KNSRKLAKIL EFVLAMGNYL NDGQPKTNKT TGFKINFLTE LNSTKTVDGK STFLHILAKS LSQHFPELLG FAQDLPTVPL AAKVNQRALT SDLADLHGTI SEIQDACQSI SPSSEDKFAM VMSSFLETAQ PALRALDGLQ REAMEELGKA LAFFGEDSKA TTSEAFFGIF AEFMSKFERA LSDLQAGEGL RSSGMVSPLA W
Explore Delphilin with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets